Caroline Gordon1, 2, 3, Maame-Boatemaa Amissah-Arthur1, Mary Gayed1, 3, Sue Brown4,
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …

Lupus, Latin for “wolf,” is a term used to describe many dermatologic conditions, some of
which are related to underlying systemic lupus erythematosus, while others are distinct …

The treatment of SLE remains complex, and management is constrained by a lack of safe,
effective, targeted therapies. Physicians, also, are constrained by a lack of evidence-based …

Objective To compare the efficacy and safety of enteric-coated mycophenolate sodium (EC-
MPS) versus azathioprine (AZA) in patients with active systemic lupus erythematosus (SLE) …

Background The objective of this study was to identify the effects of mycophenolate mofetil
(MMF) on non-renal manifestations in systemic lupus erythematosus (SLE). Methods The …

Objective. Mycophenolate mofetil (MMF), along with corticosteroids, is considered as the
standard of care in lupus nephritis (LN); however, little is known regarding its efficacy in …

Before becoming a cornerstone in the treatment of numerous immune-mediated diseases,
mycophenolate mofetil (MMF) was first introduced as an immunosuppressive agent in …

Interventions for cutaneous disease in systemic lupus erythematosus - Hannon, CW - 2021 |
Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Mycophenolate mofetil (MMF) is used off-label for systemic lupus erythematosus (SLE) and
systemic vasculitis. The study aim was to investigate clinical use and treatment results with …

Aim The aim of this study was to investigate the influence of immunosuppression following
orthotopic liver transplantation (OLT) on course of inflammatory bowel disease (IBD) …